» Articles » PMID: 20188672

Interaction with AKAP79 Modifies the Cellular Pharmacology of PKC

Overview
Journal Mol Cell
Publisher Cell Press
Specialty Cell Biology
Date 2010 Mar 2
PMID 20188672
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

A-kinase anchoring proteins (AKAPs) coordinate cell signaling events. AKAP79 brings together different combinations of enzyme binding partners to customize the regulation of effector proteins. In neurons, muscarinic agonists mobilize an AKAP79-anchored pool of PKC that phosphorylates the KCNQ2 subunit of the M channel. This inhibits potassium permeability to enhance neuronal excitability. Using a dual fluorescent imaging/patch-clamp technique, we visualized AKAP79-anchored PKC phosphorylation of the kinase activity reporter CKAR concurrently with electrophysiological changes in KCNQ2 channels to show that AKAP79 synchronizes both signaling events to optimize the attenuation of M currents. AKAP79 also protects PKC from certain ATP-competitive inhibitors. Related studies suggest that context-dependent protein-protein interactions alter the susceptibility of another protein kinase, PDK1, to ATP analog inhibitors. This implies that intracellular binding partners not only couple individual molecular events in a cell signaling process but can also change the pharmacological profile of certain protein kinases.

Citing Articles

Dehydroepiandrosterone Sulfate (DHEAS) Is an Endogenous Kv7 Channel Modulator That Reduces Kv7/M-Current Suppression and Inflammatory Pain.

Alhassen L, Alhassen W, Wong C, Sun Y, Xia Z, Civelli O J Neurosci. 2023; 43(43):7073-7083.

PMID: 37648450 PMC: 10601364. DOI: 10.1523/JNEUROSCI.2307-22.2023.


Phosphorylation, compartmentalization, and cardiac function.

Collins K, Scott J IUBMB Life. 2022; 75(4):353-369.

PMID: 36177749 PMC: 10049969. DOI: 10.1002/iub.2677.


Phosphoproteomic of the acetylcholine pathway enables discovery of the PKC-β-PIX-Rac1-PAK cascade as a stimulatory signal for aversive learning.

Yamahashi Y, Lin Y, Mouri A, Iwanaga S, Kawashima K, Tokumoto Y Mol Psychiatry. 2022; 27(8):3479-3492.

PMID: 35665767 PMC: 9708603. DOI: 10.1038/s41380-022-01643-2.


Targeting GPCRs and Their Signaling as a Therapeutic Option in Melanoma.

Raymond J, Aktary Z, Larue L, Delmas V Cancers (Basel). 2022; 14(3).

PMID: 35158973 PMC: 8833576. DOI: 10.3390/cancers14030706.


AKAP79 enables calcineurin to directly suppress protein kinase A activity.

Church T, Tewatia P, Hannan S, Antunes J, Eriksson O, Smart T Elife. 2021; 10.

PMID: 34612814 PMC: 8560092. DOI: 10.7554/eLife.68164.


References
1.
Suh B, Hille B . Recovery from muscarinic modulation of M current channels requires phosphatidylinositol 4,5-bisphosphate synthesis. Neuron. 2002; 35(3):507-20. DOI: 10.1016/s0896-6273(02)00790-0. View

2.
Hoshi N, Langeberg L, Scott J . Distinct enzyme combinations in AKAP signalling complexes permit functional diversity. Nat Cell Biol. 2005; 7(11):1066-73. PMC: 3923410. DOI: 10.1038/ncb1315. View

3.
Michel J, Townley I, Dodge-Kafka K, Zhang F, Kapiloff M, Scott J . Spatial restriction of PDK1 activation cascades by anchoring to mAKAPalpha. Mol Cell. 2005; 20(5):661-72. DOI: 10.1016/j.molcel.2005.10.013. View

4.
Carr D, Fraser I, Cone R, Scott J . Localization of the cAMP-dependent protein kinase to the postsynaptic densities by A-kinase anchoring proteins. Characterization of AKAP 79. J Biol Chem. 1992; 267(24):16816-23. View

5.
Faux M, Rollins E, EDWARDS A, Langeberg L, Newton A, Scott J . Mechanism of A-kinase-anchoring protein 79 (AKAP79) and protein kinase C interaction. Biochem J. 1999; 343 Pt 2:443-52. PMC: 1220573. View